Pharmaceutical News


Naloxone Access Pilot Programs (FAQs)

Naloxone Access Pilot Programs (FAQs)
This article will review FAQs in relation to Naloxone Access Programs being rolled out in various jurisdictions, including the ‘Take Home Naloxone’ pilot program in Australia – and why these programs need your support.

Disclaimer: This …

PharmOut Innovation Dinner

Psychedelic Therapies in Australia – the next steps forward

After Mind Medicine’s very successful International Summit on Psychedelic Therapies for Mental Illness, I’m sure the nascent industry is ablaze with ideas and inspiration.

The down-scheduling decision on MDMA and psilocybin is due to be released in Dec 2021, and …


Reducing Overdose Stigma, Saving Lives

“Reducing stigma, saving lives” is the final blog in the 10 blog series on overdose awareness and overdose prevention topics.

Did you miss the latest overdose research and overdose statistics report, released on the 31st of August 2021 (International …


Australian Regulatory Framework Psychedelic Therapies

Glancing at headlines these days there appears to be a consistent stream of positive news breaking out all over the world about the potential therapeutic benefits of psychedelics, including a declaration from the FDA that psilocybin is a “breakthrough …

Australian Overdose Statistics: An Interview with John Ryan

The latest Australian overdose statistics (2021)
This is blog 9 of 10 blogs in the overdose awareness and overdose prevention series.

The 31st of August is International Overdose Awareness Day.

We had the privilege of interviewing the Penington Institute’s CEO, John Ryan, …


Drug Safety Monitoring

Drug safety monitoring and overdose prevention
This is blog 7 of 10 blogs in the overdose awareness and overdose prevention series.

Drug safety monitoring is an important part of GMP/GxP compliance.
Drug safety monitoring includes pharmacovigilance as well as supply chain protection. …


Diversion of Pharmaceutical Products: Prevention Measures

Diversion of prescription drugs
This is Blog 5 of 10 blogs in the overdose awareness and prevention series.

Diversion of pharmaceutical products is an ongoing concern in terms of overdose deaths, as diversions can lead to potent medical substances (such …


Opioids and overdose risks

Synthetic opioids and overdose harms
This is blog 4 of 10 blogs in the overdose awareness and overdose prevention series.

What are synthetic opioids? And what are the risks of synthetic opioid overdoses and other harms?

Synthetic opioids are prescribed for …


Overdoses: Covid-19 and substance use harms

Substance use harms during Covid-19
This is blog 3 of 10 blogs in the overdose awareness and prevention series. 
Overdose risks: impact of the Covid-19 pandemic

What impact is the Covid-19 pandemic having on substance use rates?
Are changes in substance …